Virtual Reality for Neglect Diagnostics
Launched by CHARITE UNIVERSITY, BERLIN, GERMANY · Jul 20, 2011
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria for neglect patients:
- • age ≥18 and \<80 years
- • first stroke
- • neglect symptoms
- • no hemianopsia symptoms
- • consent given by the patient
- Inclusion Criteria for hemianopsia patients:
- • age ≥18 and \<80 years
- • first stroke
- • no neglect symptoms
- • hemianopsia symptoms
- • consent given by the patient
- Inclusion Criteria for Controls:
- • age ≥18 and \<80 years
- • no neurological deficits
- • informed consent
- Exclusion Criteria (for all groups):
- • language comprehension deficits
- • motor deficits of the upper extremities
- • cognitive impairments (MMSE \<20 or SKT \>15 or DEMTEC \>12)
- • depression
- • seizure disorders
- • claustrophobia
About Charite University, Berlin, Germany
Charité - Universitätsmedizin Berlin is a leading academic medical center in Germany, renowned for its commitment to excellence in research, education, and patient care. As one of Europe's largest university hospitals, Charité integrates cutting-edge clinical practices with innovative research initiatives, fostering interdisciplinary collaboration across various medical fields. The institution is dedicated to advancing healthcare through rigorous clinical trials, contributing to the development of new therapies and treatment protocols. With a strong emphasis on translational medicine, Charité aims to bridge the gap between scientific discovery and practical application, ultimately enhancing patient outcomes and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Berlin, , Germany
Patients applied
Trial Officials
Andreas Meisel, MD
Principal Investigator
Charite University (Center for Stroke Research Berlin CSB & NeuroCure Clinical Research Center NCRC)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials